Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soe Mar

Showing results (31-40 of 86) with videos related to

Pageof 9
Sort By:
Journal of Child Neurology|June 13, 2026
Global Child Neurology Capacity Building Through the Child Neurology Society International Affairs Committee: From Needs Assessment to SMART Action GoalsSharoon Qaiser, Alcy Torres, Jorge Vidaurre, et al.
International Journal of Clinical and Health Psychology : IJCHP|August 6, 2024
Increased intraindividual variability (IIV) in reaction time is the earliest indicator of cognitive change in MS: A two-year observational studyGiuseppina Pilloni, T Charles Casper, Soe Mar, et al.
Pediatric Neurology|December 28, 2023
Assessing Needs and Perceptions of Research Participation in Pediatric-Onset Multiple Sclerosis: A Multistakeholder SurveyClaudia Gambrah-Lyles, Varun Kannan, Tim Lotze, et al.
Journal of Neurosurgery. Pediatrics|March 25, 2017
The use of hippocampal volumetric measurements to improve diagnostic accuracy in pediatric patients with mesial temporal sclerosisGloria J Guzmán Pérez-Carrillo, Christopher Owen, Katherine E Schwetye, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 17, 2024
Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosisEllen O'Donnell, Allison Schuette, Michael Waltz, et al.
Multiple Sclerosis and Related Disorders|April 11, 2025
Childhood adversity in parents of patients with pediatric multiple sclerosisKimberly A O'Neill, Leigh Charvet, Allan George, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosisCarolyn E Schwartz, Stephanie A Grover, Victoria E Powell, et al.
Neurology|October 19, 2018
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the USKristen M Krysko, Jennifer Graves, Mary Rensel, et al.
Journal of Neurology|January 15, 2025
Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I studySoe Mar, Massimiliano Valeriani, Barbara Steinborn, et al.
Multiple Sclerosis and Related Disorders|March 15, 2025
Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated diseaseRebecca MacRae, Jonathan Race, Allison Schuette, et al.
Pageof 9

Showing results (31-40 of 86) with videos related to

Sort By:
Pageof 9
Journal of Child Neurology|June 13, 2026
Global Child Neurology Capacity Building Through the Child Neurology Society International Affairs Committee: From Needs Assessment to SMART Action GoalsSharoon Qaiser, Alcy Torres, Jorge Vidaurre, et al.
International Journal of Clinical and Health Psychology : IJCHP|August 6, 2024
Increased intraindividual variability (IIV) in reaction time is the earliest indicator of cognitive change in MS: A two-year observational studyGiuseppina Pilloni, T Charles Casper, Soe Mar, et al.
Pediatric Neurology|December 28, 2023
Assessing Needs and Perceptions of Research Participation in Pediatric-Onset Multiple Sclerosis: A Multistakeholder SurveyClaudia Gambrah-Lyles, Varun Kannan, Tim Lotze, et al.
Journal of Neurosurgery. Pediatrics|March 25, 2017
The use of hippocampal volumetric measurements to improve diagnostic accuracy in pediatric patients with mesial temporal sclerosisGloria J Guzmán Pérez-Carrillo, Christopher Owen, Katherine E Schwetye, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 17, 2024
Patient and family views on research priorities and design of clinical trials and research studies in pediatric multiple sclerosisEllen O'Donnell, Allison Schuette, Michael Waltz, et al.
Multiple Sclerosis and Related Disorders|April 11, 2025
Childhood adversity in parents of patients with pediatric multiple sclerosisKimberly A O'Neill, Leigh Charvet, Allan George, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Risk factors for non-adherence to disease-modifying therapy in pediatric multiple sclerosisCarolyn E Schwartz, Stephanie A Grover, Victoria E Powell, et al.
Neurology|October 19, 2018
Use of newer disease-modifying therapies in pediatric multiple sclerosis in the USKristen M Krysko, Jennifer Graves, Mary Rensel, et al.
Journal of Neurology|January 15, 2025
Ocrelizumab dose selection for treatment of pediatric relapsing-remitting multiple sclerosis: results of the OPERETTA I studySoe Mar, Massimiliano Valeriani, Barbara Steinborn, et al.
Multiple Sclerosis and Related Disorders|March 15, 2025
Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated diseaseRebecca MacRae, Jonathan Race, Allison Schuette, et al.
Pageof 9